Who Paid My Doc
Fluzone Quadrivalent
Biological Vaccines
NDC 49281-421-10
General payments
$110,338
Research payments
$2,617,591
Through program year 2021, $110,338 in general payments and $2,617,591 in research payments were reported against Fluzone Quadrivalent (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $110,319 | 5,396 |
| 2021 | Research | $2,617,591 | 41 |
| 2020 | General | $19 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 76 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
5,397 general · 41 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.